Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $336.67 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $153.93 | 7 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $61.57 | 3 | $0 (2019) |
| Relypsa, Inc. | $31.99 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $24.71 | 1 | $0 (2018) |
| Arbor Pharmaceuticals, Inc. | $19.24 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.70 | 1 | $0 (2017) |
| PFIZER INC. | $15.74 | 1 | $0 (2019) |
| Medtronic Vascular, Inc. | $10.79 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $78.84 | 4 | E.R. Squibb & Sons, L.L.C. ($41.55) |
| 2018 | $149.08 | 7 | Novartis Pharmaceuticals Corporation ($85.86) |
| 2017 | $108.75 | 6 | Novartis Pharmaceuticals Corporation ($46.52) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/16/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.00 | General |
| Category: Cardiovascular | ||||||
| 05/06/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.55 | General |
| Category: Cardiovascular | ||||||
| 02/27/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/08/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/27/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.02 | General |
| Category: Cardiovascular | ||||||
| 10/11/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/14/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/24/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Hyperkalemia | ||||||
| 04/12/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/28/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/05/2017 | Medtronic Vascular, Inc. | SEEQ (Device) | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 09/21/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Hyperkalemia | ||||||
| 08/31/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/03/2017 | Arbor Pharmaceuticals, Inc. | Bidil (Drug) | Food and Beverage | Cash or cash equivalent | $19.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/30/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/09/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRAXBIND (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 29 | 29 | $7,511 | $1,598 |
| 2022 | 1 | 46 | 46 | $11,914 | $2,773 |
| 2021 | 2 | 45 | 48 | $10,248 | $2,497 |
| 2020 | 1 | 13 | 13 | $1,677 | $515.72 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 29 | 29 | $7,511 | $1,598 | 21.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 46 | 46 | $11,914 | $2,773 | 23.3% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 34 | 34 | $8,806 | $2,168 | 24.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 11 | 14 | $1,442 | $329.50 | 22.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 13 | 13 | $1,677 | $515.72 | 30.8% |
About Dr. Jonathan Patrick, MD
Dr. Jonathan Patrick, MD is a Cardiovascular Disease healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821027475.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Patrick, MD has received a total of $336.67 in payments from pharmaceutical and medical device companies, with $78.84 received in 2019. These payments were reported across 17 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($336.67).
As a Medicare-enrolled provider, Patrick has provided services to 133 Medicare beneficiaries, totaling 136 services with total Medicare billing of $7,384. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Washington, DC
- Active Since 07/03/2006
- Last Updated 09/12/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1821027475
Products in Payments
- ENTRESTO (Drug) $153.93
- ELIQUIS (Drug) $61.57
- Veltassa (Drug) $31.99
- BRILINTA (Drug) $24.71
- Bidil (Drug) $19.24
- PRAXBIND (Drug) $18.70
- CHANTIX (Drug) $15.74
- SEEQ (Device) $10.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Washington
Dr. Toby Rogers
Cardiovascular Disease — Payments: $812,095
Hayder Hashim, M.d, M.D
Cardiovascular Disease — Payments: $573,299
Dr. Joshua Yamamoto, M.d, M.D
Cardiovascular Disease — Payments: $423,212
Zayd Eldadah, Md, Phd, MD, PHD
Cardiovascular Disease — Payments: $379,254
Mardi Gomberg-Maitland, Md, MD
Cardiovascular Disease — Payments: $305,036
Jonathan Reiner, M.d, M.D
Cardiovascular Disease — Payments: $220,893